Long-Acting Amylin Agonist GUB014295 Gubra A/S (Hrsholm, Denmark), a biotech company specialized in pre-clinical contract research, initiated a phase 1 clinical trial (NCT06144684) to investigate the safety, tolerability and pharmacological properties of GUB014295 (GUBamy), a long-acting OW SC amylin agonist, in healthy volunteers [117]
This timing allows peak tissue levels to coincide with the first sleep cycle when growth hormone release and collagen synthesis are highest
Soon after Wegovys approval in 2021, many telehealth companies partnered with compounding pharmacies to sell cheaper, compounded GLP-1 drugs, often with the justification of the standard drugs being in shortage
Greger exposed whats really happening in our bodies when we take drugs like Ozempic, explaind why we should be concerned about supplements purported to act as natures Ozempic, and discussed the foods, beverages, spices, and lifestyle habits that can actually boost GLP-1 activity, cut cravings, and accelerate the loss of body fat
Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial
